BackLifecore Biomedical Overview
Lifecore Biomedical Inc

Lifecore Biomedical Target Price

Where could LFCR trade next? Consensus target price: $6.5.

Get informed when a big investor buys or sells

+ Follow

Share Price

$4.74

Average Target Price

$6.5037.1% upside

1 analysts in the last 4 months

High: $6.5 | Low: $6.5

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-06-16Barrington$6.537.1% upsideOpen
2026-04-29Barrington$626.6% upsideOpen
2024-10-04StephensJacob Johnson$55.5% upsideOpen
2024-09-05Craig-HallumMatthew Hewitt$868.8% upsideOpen

Lifecore Biomedical (LFCR) FAQ

As of the most recent data, LFCR shows a target price of $6.5. Scroll down for historical charts and peer comparison views.

If Lifecore Biomedical moved to the average analyst target of $6.5, shares would be roughly 37.1% higher than $4.74. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Lifecore Biomedical's earnings trajectory.

Besides this target price page, Stockcircle has Lifecore Biomedical's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $6.5) with ownership activity and broader fundamentals.

Lifecore Biomedical's target price is $6.5; compare it with other Materials names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.